ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in ImageneBio, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −5 vs. Q1 2025
- Shares held
- 31.8M
- −985.8K (−3.0%) vs. Q1 2025
- Total value
- $42.6M
- +$646.8K (+1.5%) vs. Q1 2025
- New holders
- 4
- 8 more added
- Sold out
- 9
- 10 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $6.72M | 1.02% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 4,091,118 | $5.48M | 1.77% | 00.0% | Unchanged |
| BML Capital Management, LLC | 4,030,102 | $5.40M | 4.14% | +319,299+8.6% | Added |
| BVF Inc | 4,006,564 | $5.37M | 0.19% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,539,358 | $4.74M | 0.12% | 00.0% | Unchanged |
| Deep Track Capital, LP | 2,515,513 | $3.37M | 0.11% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 2,249,123 | $3.01M | 1.95% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,413,649 | $1.89M | 0.00% | +30,231+2.2% | Added |
| Adage Capital Partners GP, L.L.C. | 800,000 | $1.07M | 0.00% | 00.0% | Unchanged |
| NEA Management Company, LLC | 600,063 | $804.1K | 0.06% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 382,616 | $512.7K | 0.03% | 00.0% | Unchanged |
| BlackRock, Inc. | 357,936 | $479.6K | 0.00% | +9,302+2.7% | Added |
| Gilead Sciences, Inc. | 348,534 | $467.1K | 0.04% | −810,611−69.9% | Reduced |
| Renaissance Technologies LLC | 308,856 | $413.9K | 0.00% | +14,369+4.9% | Added |
| Geode Capital Management, LLC | 307,972 | $412.8K | 0.00% | −9,119−2.9% | Reduced |
| Aldebaran Capital, LLC | 242,116 | $324.4K | 0.32% | −5,679−2.3% | Reduced |
| Acadian Asset Management LLC | 209,568 | $278.0K | 0.00% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 198,107 | $265.5K | 0.00% | −47,378−19.3% | Reduced |
| Citadel Advisors LLC | 158,215 | $212.0K | 0.00% | +78,528+98.5% | Added |
| Bridgeway Capital Management, LLC | 153,300 | $205.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 144,100 | $193.1K | 0.00% | −7,300−4.8% | Reduced |
| State Street Corp | 92,153 | $123.5K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 84,680 | $113.5K | 0.00% | +7,246+9.4% | Added |
| UBS Group AG | 74,661 | $100.0K | 0.00% | −25,999−25.8% | Reduced |
| Goldman Sachs Group Inc | 66,664 | $89.3K | 0.00% | −9,800−12.8% | Reduced |
| Barclays PLC | 66,177 | $88.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 58,957 | $79.0K | 0.00% | −20,465−25.8% | Reduced |
| Northern Trust Corp | 57,565 | $77.1K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 49,315 | $66.1K | 0.00% | −20,369−29.2% | Reduced |
| Dimensional Fund Advisors LP | 38,621 | $51.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 27,416 | $36.7K | 0.00% | +14,845+118.1% | Added |
| Berkshire Asset Management LLC | 20,000 | $26.8K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 16,999 | $22.8K | 0.00% | −39,453−69.9% | Reduced |
| Royal Bank of Canada | 16,000 | $21.0K | 0.00% | +16,000 | New |
| Susquehanna International Group, LLP | 13,141 | $17.6K | 0.00% | +13,141 | New |
| Tower Research Capital LLC (TRC) | 2,275 | $3.05K | 0.00% | +2,275 | New |
| JPMorgan Chase & Co | 849 | $1.14K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 547 | $733 | 0.00% | +326+147.5% | Added |
| Wells Fargo & Company | 500 | $670 | 0.00% | +500 | New |
| BNP Paribas Arbitrage, SA | 315 | $422 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 3 | $4 | 0.00% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 0 | $0 | 0.00% | −296,437−100.0% | Sold out |
| Deuterium Capital Management, LLC | 0 | $0 | 0.00% | −80,579−100.0% | Sold out |
| BBR Partners, LLC | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −16,952−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −5,063−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −525−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −69−100.0% | Sold out |